DE69637431D1 - UNGENE AND ITS USE - Google Patents

UNGENE AND ITS USE

Info

Publication number
DE69637431D1
DE69637431D1 DE69637431T DE69637431T DE69637431D1 DE 69637431 D1 DE69637431 D1 DE 69637431D1 DE 69637431 T DE69637431 T DE 69637431T DE 69637431 T DE69637431 T DE 69637431T DE 69637431 D1 DE69637431 D1 DE 69637431D1
Authority
DE
Germany
Prior art keywords
ungene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69637431T
Other languages
German (de)
Other versions
DE69637431T2 (en
Inventor
Enzo Paoletti
Steven E Pincus
William I Cox
Elizabeth K Kauffman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Virogenetics Corp
Original Assignee
Virogenetics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/658,665 external-priority patent/US5997878A/en
Application filed by Virogenetics Corp filed Critical Virogenetics Corp
Application granted granted Critical
Publication of DE69637431D1 publication Critical patent/DE69637431D1/en
Publication of DE69637431T2 publication Critical patent/DE69637431T2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • C07K16/088Varicella-zoster virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • C07K16/089Cytomegalovirus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/16011Herpesviridae
    • C12N2710/16111Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/20011Rhabdoviridae
    • C12N2760/20111Lyssavirus, e.g. rabies virus
    • C12N2760/20122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69637431T 1995-06-06 1996-06-06 RECOMBINANT POXVIRUS CYTOMEGALOVIRUS COMPOSITIONS AND ITS USE Expired - Fee Related DE69637431T2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US47101495A 1995-06-06 1995-06-06
US471014 1995-06-06
US08/658,665 US5997878A (en) 1991-03-07 1996-06-05 Recombinant poxvirus-cytomegalovirus, compositions and uses
US658665 1996-06-05
PCT/US1996/009454 WO1996039491A1 (en) 1995-06-06 1996-06-06 Recombinant poxvirus - cytomegalovirus compositions and uses

Publications (2)

Publication Number Publication Date
DE69637431D1 true DE69637431D1 (en) 2008-03-27
DE69637431T2 DE69637431T2 (en) 2009-04-16

Family

ID=40435814

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69637431T Expired - Fee Related DE69637431T2 (en) 1995-06-06 1996-06-06 RECOMBINANT POXVIRUS CYTOMEGALOVIRUS COMPOSITIONS AND ITS USE

Country Status (1)

Country Link
DE (1) DE69637431T2 (en)

Also Published As

Publication number Publication date
DE69637431T2 (en) 2009-04-16

Similar Documents

Publication Publication Date Title
DE69637691D1 (en) AZEOTROPĂ„HNLICHE COMPOSITIONS AND THEIR USE
DE69638056D1 (en) AZEOTROPĂ„HNLICHE COMPOSITIONS AND THEIR USE
DE69634142D1 (en) NOVEL AFFINITY SILICONES AND THEIR USE
DE69820397D1 (en) Etchants and their use
DE69534265D1 (en) CHIMERIC CYTOKINS AND ITS USE
DE69602787D1 (en) Rotational brake and its use
DE59712887D1 (en) SUBSTITUTED PHENYLKETOENOLE AND THEIR USE AS PESTICIDES
DE69519101D1 (en) MHC COMPLEXES AND THEIR USE
DE69532671D1 (en) ENDOPROTHESES AND STENTS
DE69620270T2 (en) Shortening and its use
DE69635673D1 (en) BLUTSAMMELSYSTEM AND COUPLING
DE69627188D1 (en) EYEWEAR AND EYEWEAR
DE69513307T2 (en) COMPOSITION AND USE
BR9506832A (en) N-pyrazolylanilines and n-pyrazolylaminopyridines
DE69418203D1 (en) CEMENTING AGENTS AND THEIR USE
DE69806419D1 (en) Resin composition and its use
DE69620914D1 (en) PERFLUORALKOXYCYCLOALKANCARBONYLFLUORID COMPOSITIONS AND THEIR USE
DE69723818D1 (en) POLYESTERANHYDRIDE AND ITS INTERMEDIATE PRODUCTS
DE69620243T2 (en) MAIN AND BY-FLOW FILTER
DE69615714D1 (en) PHOSPHATE COMPOSITION AND THEIR USE
DE69332815D1 (en) Polyglyzidyl ethers and their use
DE69521174D1 (en) ANTHRACINE DERIVATIVES WITH ANTITUARY EFFECT AND THEIR USE
DE59708683D1 (en) Copper-chrome-titanium-silicon alloy and its use
DE59607383D1 (en) Dye mixtures and their use
DE69732095D1 (en) IONOMIC COMPOSITION AND ITS USE

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee